NCT07001072Not yet recruiting
Smartshoes for Freezing of Gait in Parkinson's Disease
Mitigating Freezing of Gait (FoG) in Parkinson's Disease With Spatiotemporal Haptic Feedback Delivered by Smartshoes
Source: ClinicalTrials.gov · Last updated 8 May 2026
Brief summary (registry, in English)
This is a pilot research study aimed at evaluating whether an FDA listed wearable shoe with capability to deliver vibration feedback can be safe and tolerable for patients with Parkinson disease and control participants and explore whether such a feedback can be useful for treating freezing of gait (FOG) in patients with Parkinson disease.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 20 May 2025
- Start date
- 1 Sept 2026
- Primary completion date
- 30 Sept 2027
- Lead sponsor
- Stanford University
- Diseases
- Parkinson disease
- NCT number
- NCT07001072
What you commit to
- Study type: Interventional
- Planned participants: 20
- From 1 Sept 2026 to the primary completion date, 30 Sept 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients with dementia (MoCA\<18) who are not able to appropriately provide consent for the study
Age
- For all participants (PD with or without freezing, or age-matched controls)
Other
- moderate to severe peripheral neuropathy (based on self report or clinical exam using vibration tuning fork) which may limit ability to sense the vibratory feedback
- use of orthotics incompatible with the haptic wearable shoes
- severe balance deficits or daily falls at baseline
- pregnant persons
Who the study is looking for
- For patients with Parkinson disease:
- diagnosis of PD according to the UK Brain Bank criteria
- Hoehn and Yahr stages 2 to 3 during the ON phase of PD medication
- Self-report episodes of FoG based on item 1 of the NFOG-Q, and score of 3 on item 2, part II
- For patients with Parkinson disease withOUT freezing of gait:
- diagnosis of PD according to the UK Brain Bank criteria
- Hoehn and Yahr stages 2 to 3 during the ON phase of PD medication
- For all participants (PD with or without freezing, or age-matched controls):
- adult age 40-80
- able to walk 10 minutes at baseline
- able to provide consent
- able to read and write in English at an 8th grade level.
Age in the registry: 40 years to 80 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Stanford University Coordinator of this site? Confirm its status | Palo Alto | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.